Evolving antitrust strategies for healthcare deals in 2023
Davis Polk recently hosted its second in its current series of webinars focused on legal considerations for life sciences and healthcare companies.
In this second installment, Davis Polk addressed strategies for navigating antitrust risks for life sciences and healthcare deals in a rapidly changing enforcement landscape. Topics covered included:
- How antitrust authorities are targeting the sector
- How to approach deal negotiations, diligence and clearance strategy in the current landscape
- Recent case studies of healthcare antitrust enforcement
This program is designed for in-house counsel, corporate development executives and strategic decision-makers.